Related Experiment Video
Updated: Jul 15, 2025

07:32
Locomotor Assessment of 6-Hydroxydopamine-induced Adult Zebrafish-based Parkinson's Disease Model
Published on: December 28, 2021
4.0K
Advances in Neurorestoratology-Current status and future developments.
Hongyun Huang1, Almudena Ramon-Cueto2, Wagih El Masri3
1Beijing Hongtianji Neuroscience Academy, Beijing, P.R. China.
International Review of Neurobiology
|October 2, 2023
Summary
Neurorestoratology offers novel strategies for repairing the central nervous system (CNS). This field integrates mechanisms like neurogenesis and neuroplasticity to restore neurological functions and improve treatments for CNS diseases.
Area of Science:
- Neuroscience
- Regenerative Medicine
- Neurology
Background:
- Neurorestoratology is an emerging discipline focused on restoring damaged neural structures and functions.
- It consolidates concepts and strategies for neurorestoration, building on the understanding that the central nervous system (CNS) can repair itself.
Purpose of the Study:
- To introduce Neurorestoratology to a broader academic and public audience.
- To explain the origins and scientific basis of neurorestorative mechanisms.
- To review the current state of the field, including advancements and future directions.
Main Methods:
- Review of scientific literature and evidence supporting neurorestorative mechanisms.
- Exploration of the development, achievements, and outcomes of neurorestorative treatments.
- Analysis of the role of multidisciplinary expert associations and specialized journals.
Main Results:
- Identified key neurorestorative mechanisms including neuroprotection, neuroplasticity, neurogenesis, neuroregeneration, neuroreplacement, remyelination, and angiogenesis.
- Highlighted the progress in novel neurorestorative treatments and evaluation procedures.
- Emphasized the growing impact of multidisciplinary collaboration and specialized publications in the field.
Conclusions:
- Neurorestoratology is rapidly evolving, integrating diverse strategies for CNS repair.
- The discipline holds significant promise for improving therapeutic approaches to neurological diseases.
- Future advancements are expected, particularly in comprehensive cell-based treatments for functional recovery in patients with neurological deficits.
Related Concept Videos
Alzheimer's Disease: Overview
513
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
513
Neurogenesis and Regeneration of Nervous Tissue
848
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
848
Neuroplasticity
411
Neuroplasticity reflects the brain's remarkable capacity to adapt and evolve, responding dynamically to learning, experiences, or injury by reorganizing its neural circuitry. This reorganization involves creating new neural connections and refining old ones through a series of biological processes that contribute to the brain's lifelong development and adaptability.
411
Parkinson's Disease: Overview
590
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
590
Alzheimer's Disease: Treatment
212
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
212

